Carbaglu Tablet, For Suspension
Product Images NDC 52276-312

Recordati is a company that deals with rare diseases.*

This is a pharmaceutical label for Carbaglu 200 mg tablets for oral suspension. The label specifies instructions for keeping the medication, the dosage and administration, and the name of the trademark holder. The tablets should be dispersed in water and not swallowed whole or crushed. The medication should be refrigerated at 2°C-8°C before opening and not stored above 30°C after opening. Users should keep the container tightly closed to protect from moisture and put the date of first opening on the carton and the tablet container. The medication should be discarded one month after first opening.*

This is a medication and the text provides instructions on how to use and store it. The dosage and administration information can be found on the package insert. After opening the container, the medication should be stored in a tightly closed container to protect it from moisture. The date of the first opening should be written on both the carton and tablet container. The medication should not be used after the expiration date and should be discarded one month after the first opening. To keep it safe, the medication should be kept out of children's reach. The rest of the text is not readable.*

Carbaglu is a medication available in the form of tablets for oral suspension, containing carglumic acid at 200mg. It is supplied as a white, elongated, scored and coded tablet with 'C' on one side, packaged in a carton. The tablet is required to be dispersed in water and not to be swallowed whole or crushed. The medication needs to be refrigerated at 2-8°C (36°-46°F) before opening, and after opening, it cannot be refrigerated and should not be stored above 30°C (86°F). Children should not have access to the medication. The medication should be discarded one month from the date of first opening. The package insert includes dosage and administration instructions. The medication is distributed by RecordatiRare Diseases Inc. and carries the trademark Carbaglu.*

Dosage and Administration information for Nog s2276-312 is available on the package insert. After opening, keep the container closed to protect the contents. Record the date of first opening on the carton and container. Do not use after the expiration date indicated and discard one month after opening. Cataglutis is a trademark of Recordat Rare Diseases. Keep out of reach of children. No further information available.*

This appears to be a chart or graph related to the percentage of events related to treatment with a drug called CARBAGLU versus a placebo, over a period of three days. The chart indicates that there were significantly fewer events in the group treated with CARBAGLU versus the placebo. However, without more information about what the events were or what the study was measuring, it is difficult to provide a more detailed description.*